Consistent with the association of the A allele for rs3777909 with increased MFSD4B and REV3L expression and increased vertigo, there was an inverse relationship between MFSD4B expression and cisplatin AUC in cancer cell lines in silico (R = −0.12; p = 5.8 × 10−3; Figure 4E) and between REV3L expression and cisplatin AUC (R = −0.17; p = 5.1 × 10−5; Figure 4F) in cancer cell lines in silico, indicating that increased MFSD4B and REV3L expression was significantly associated with increased cellular sensitivity to cisplatin. This evidence concerns the gene REV3L and Vertigo.